TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva

British Journal of Cancer

Volumn 89, Issue 12, 2003, Pages 2249-2253

  Rolfe, K J ^a,b   MacLean, A B ^a   Crow, J C ^a   Benjamin, E ^a   Reid, W M N ^a   Perrett, C W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Immunohistochemistry; Lichen sclerosus; Mutation; p53; Squamous cell carcinoma of the vulva

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CLONE; COMPARATIVE STUDY; DNA SEQUENCE; EPIDERMIS; FEMALE; GENE MUTATION; GENETIC PROCEDURES; GENETICS; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MICRODISSECTION; MUTATION; MUTATIONAL ANALYSIS; PATHOGENESIS; PATHOLOGY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VULVA; VULVA CARCINOMA; VULVA TUMOR;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, P53; GENETIC TECHNIQUES; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; MUTATION; PRECANCEROUS CONDITIONS; VULVA; VULVAR NEOPLASMS;

EID: 0842330369     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601444     Document Type: Article

References (35)

1. Ames BN, Gold LS (1990) Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci USA 87: 7772
2. Burmer GC, Crispin DA, Kolli VR, Haggitt RC, Kulander BG, Rubin CE, Rabinovitch PS (1991) Frequent loss of a p53 allele in carcinomas and their precursor in ulcerative colitis. Cancer Commun 3: 167-172
3. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE (1992) Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of p53 allele. Gastroenterology 103: 1602-1610
4. Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P, Figge H, Mihn Jr MC (1998) Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective: implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 29: 932-948
5. Carlson JA, Grabowski R, Paunovich E, Chichester P, Paunovich E, Malfetano J (2000) Comparative immunophenotypic study of lichen sclerosus: epidermotrophic CD57+ lymphocytes are numerous - implications for pathogenesis. Am J Dermatopathol 22: 7-16
6. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA (1993) Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676-1683
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
8. Harris CC, Hsu IC, Stoner GD, Trump BF, Selkirk JK (1978) Human pulmonary alveolar macrophages metabolise benzo (a) pyrene to proximate and ultimate mutagens. Nature 272: 633-634
9. Hart WR, Norris HJ, Helwig EB (1975) Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 45: 369-377
10. Hietanen SH, Kurvinen K, Syrjänen K, Grenman S, Carey T, McClatchey K, Syrjanen S (1995) Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 173: 1477-1482
11. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acid Res 24: 141-146
12. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ (1993) Altered messenger RNA and unique mutational profile of p53 and Rb in human esophageal carcinomas. Cancer Res 53: 1889-1894
13. Kim YT, Thomas NF, Kessis TD, Wilkinson EJ, Hendrick L, Cho KR (1996) P53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Hum Pathol 27: 389-395
14. Laude TA, Narayanaswamy G, Rajkumar S (1980) Lichen sclerosus et atrophicus in an eleven year old girl. Cutis 26: 78-80
15. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456
16. Meffert JJ, Davis BM, Grimwood RE (1995) Lichen sclerosus. J Am Acad Dermatol 32: 393-416
17. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T (1995) Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and vulva. Int J Cancer 63: 639-645
18. Ngan HYS, Cheung ANY, Liu SS, Yip PS, Tsao SW (1999) Abnormal expression or mutation of TP53 and HPV in vulvar cancer. Eur J Cancer 35: 481-484
19. Pilotti S, D'Amato L, Della Torre G, Donghi R, Longoni A, Giarola M, Sampietro G, De Palo G, Pierotti MA, Rilke F (1995) Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Diag Mol Pathol 4: 239-248
20. Ren ZP, Hedrum A, Pontén F, Nister M, Ahmadian A, Lundeberg J, Uhlen M, Ponten J (1996) Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 12: 765-773
21. Rolfe KJ, Crow JC, Reid WMN, Benjamin E, MacLean AB, Perrett CW (2002) The effects of topical steroids on p53 and Ki67 in vulval lichen sclerosus. Br J Dermatol 147: 503-508
22. Rolfe KJ, Eva KJ, MacLean AB, Crow JC, Perrett CW, Reid WMN (2001) Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynaecol Cancer 11: 113-118
23. Rueda GN, Vighi S, Garcia A, Cardinal L, Belardi MG, di Paola G (1994) Epithelial alterations adjacent to invasive squamous carcinoma of the vulva. J Reprod Med 39: 526-530
24. Scurry J, Navin K, Östörs A (1997) Comparison of histological features of vulvar lichen sclerosus with and without adjacent squamous cell carcinoma. Int J Gynecol Cancer 7: 392-399
25. Sliutz G, Schmidt W, Tempfer C, Speiser P, Gitsch G, Eder S, Schneeberger C, Kainz C, Zellinger R (1997) Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis. Gynecol Oncol 64: 93-98
26. Stephen CW, Helminen P, Lane DP (1995) Characterisation of epitopes on human p53 using phage-displayed peptide libraries: Insights into antibody peptide interactions. J Mol Biol 248: 58-78
27. Tsang WYW, Chan JKC (1992) KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker for lysozymes rather than histocytic lineage? Histopathology 21: 84-86
28. Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, Le Doussal V (2000) Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynecol Oncol 19: 25-31
29. Vojtesek B, Bartek J, Midgley CA, Lane DP (1992) An immunochemical analysis of the human nuclear phosphoprotein-p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244
30. Wallace HJ (1971) Lichen sclerosus et atrophicus. Trans St. John's Hosp Dermatol Soc 57: 9-30
31. Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP (1983) Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med 308: 26-30
32. Weitzman SA, Stossel TP (1981) Mutation caused by human phagocytes. Science 212: 546-547
33. Wynford-Thomas D (1992) p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166: 329-330
34. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, Hontanosas M, Newkirk C, Meltzer SJ (1993) p53 point mutations in dysplastic and cancerous colitis lesions. Gastroenterology 104: 1633-1639
35. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE (1994) Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776